SCHEMBL472714

SCHEMBL472714

CCCCCCCc1cc(O)nc2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.59
MAPT P10636 2/20 0.59
KDM4E B2RXH2 2/20 0.59
ALDH1A1 P00352 2/20 0.59
GAA P10253 2/20 0.59
HPGD P15428 2/20 0.59
USP2 O75604 1/20 0.59
GLA P06280 1/20 0.59
CASP1 P29466 1/20 0.59
CASP7 P55210 1/20 0.59
HSD17B10 Q99714 1/20 0.59
TLR8 Q9NR97 12/20 0.50
TSHR P16473 2/20 0.48
LMNA P02545 1/20 0.48
LIPG Q9Y5X9 1/20 0.46
ATM Q13315 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MEN1 O00255 1/20 0.45
TP53 P04637 1/20 0.45
ALOX5 P09917 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22926881 0.98 KDM4E (0.56) CYP3A4MAPTKDM4EALDH1A1GAA
SCHEMBL11038698 0.82 KDM4E (0.53) CYP3A4MAPTKDM4EALDH1A1GAA
SCHEMBL20414372 0.80 DHODH (0.52) CYP3A4MAPTKDM4EALDH1A1GAA
SCHEMBL28623461 0.80 ALOX15 (0.54) CYP3A4MAPTKDM4EALDH1A1GAA
SCHEMBL2532916 0.80 TNKS2 (0.46) MAPTKDM4EALDH1A1GAAHPGD
SCHEMBL10630961 0.79 TLR8 (0.59) CYP3A4MAPTKDM4EALDH1A1GAA
SCHEMBL7262455 0.78 KDM4E (0.43) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL9988793 0.78 DHODH (0.53) CYP3A4MAPTKDM4EALDH1A1GAA
SCHEMBL7550406 0.78 TLR8 (0.55) CYP3A4MAPTKDM4EALDH1A1GAA
SCHEMBL7548623 0.78 TLR8 (0.55) CYP3A4MAPTKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598651-A1 METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND ASSOCIATED WITH BACTERIAL INFECTION Sanofi-Aventis Deutschland GmbH (DE) 2013-06-05 EP disclosed
US-20130123360-A1 METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND ASSOCIATED WITH BACTERIAL INFECTION SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2013-05-16 US disclosed
WO-2012013621-A1 METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND ASSOCIATED WITH BACTERIAL INFECTION SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2012-02-02 WO disclosed
EP-2412819-A1 Methods and uses relating to the identification of compound associated with bacterial infection Sanofi-Aventis Deutschland GmbH (DE) 2012-02-01 EP disclosed